Denagard®
Now from Novartis
Denagard® (tiamulin) is a proven, broad-spectrum
antibiotic for control and treatment of certain swine bacterial
diseases. With a track record of efficacy and reliability in
over 50 countries worldwide, tiamulin, Denagard’s active
ingredient, is highly effective against several diseases that
have a significant economic impact on swine production.
|
|
| Denagard
10 Medicated Premix Highlights |
Control
ileitis
- Proven effective in control of ileitis associated with Lawsonia intracellularis |
Use
with chlortetracycline (CTC)
- Denagard 10 and CTC are approved for concurrent use to provide
enteric and respiratory disease coverage, respectively |
Controls
and treats swine dysentery
- Effective against Brachyspira (Serpulina) hyodysenteriae |
| Coated,
granular premix reduces dustiness and ensures consistent mixing
and dispersal in finished feed |
| Dosage
and administration instructions |
| Denagard
Liquid Concentrate Highlights |
Treats
swine pneumonia
- Effective against Actinobacillus pleuropneumoniae |
Treats
swine dysentery
- Effective against Brachyspira (Serpulina) hyodysenteriae |
Fast,
effective treatment
- Water medication can quickly and conveniently be administered
- Product is in solution, so it’s easy to mix
- Response is usually evident in 24 to 48 hours; tiamulin is
readily absorbed from the gut and can be found in the blood
within 30 minutes after dosing |
| Usage
instructions |
Caution: Do not feed Denagard
10 undiluted. Do not use in feeds for animals other than swine.
Contraindications: Swine being treated with Denagard (tiamulin)
should not have access to feeds containing polyether ionophores
(e.g., lasalocid, monensin, narasin, salinomycin and semduramicin)
as adverse reactions may occur. See product label for directions
for use and additional information.
Caution: Do not use Denagard
Liquid Concentrate undiluted. Contraindications:
Swine being treated with Denagard (tiamulin) should not have access
to feeds containing polyether ionophores (e.g., lasalocid, monensin,
narasin, salinomycin and semduramicin) as adverse reactions may
occur. See product label for directions for use and additional information.
|
